These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6140228)

  • 41. Biomarkers for the effects of antipsychotic drugs in healthy volunteers.
    de Visser SJ; van der Post J; Pieters MS; Cohen AF; van Gerven JM
    Br J Clin Pharmacol; 2001 Feb; 51(2):119-32. PubMed ID: 11259983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic fate of zetidoline, a new neuroleptic agent, in man.
    Assandri A; Perazzi A; Ferrari P; Martinelli E; Ripamonti A; Tarzia G; Tuan G
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):341-7. PubMed ID: 2858825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers.
    McClelland GR; Cooper SM; Pilgrim AJ
    Br J Clin Pharmacol; 1990 Dec; 30(6):795-803. PubMed ID: 2288826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies--Part I.
    Saletu B; Grünberger J; Linzmayer L; Dubini A
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):489-95. PubMed ID: 6139346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prolactin-releasing effect of zetidoline, a new neuroleptic agent, in the rat.
    Galliani G; Restelli A; Rosina R; Glässer A
    Pharmacol Res Commun; 1984 Feb; 16(2):117-27. PubMed ID: 6150500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Classification and determination of the pharmacodynamics of a new tetracyclic antidepressive agent, pirlindol, using pharmaco-EEG and psychometry].
    Saletu B; Grünberger L; Linzmayer L; Wittek R; Stöhr H
    Wien Klin Wochenschr; 1983 Jul; 95(14):481-93. PubMed ID: 6356628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
    Saletu B; Grünberger J; Linzmayer L; Stöhr H
    Int J Clin Pharmacol Res; 1984; 4(2):95-107. PubMed ID: 6469443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sertindole: a review of clinical efficacy.
    Kane JM
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S59-63; discussion S63-4. PubMed ID: 9690972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers.
    Rosenzweig P; Canal M; Patat A; Bergougnan L; Zieleniuk I; Bianchetti G
    Hum Psychopharmacol; 2002 Jan; 17(1):1-13. PubMed ID: 12404702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies: Part II.
    Saletu B; Grünberger J; Linzmayer L; Dubini A
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):544-51. PubMed ID: 6140228
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.